Skip to main content

8 MS Pill - yellow capsule/oblong

Pill with imprint 8 MS is Yellow, Capsule/Oblong and has been identified as Sunitinib Malate 37.5 mg. It is supplied by Novadoz Pharmaceuticals LLC.

Sunitinib is used in the treatment of Renal Cell Carcinoma; Gastrointestinal Stromal Tumor; Pancreatic Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 8 MS

Sunitinib Malate

Imprint
8 MS
Strength
37.5 mg
Color
Yellow (yellow opaque body and yellow opaque cap)
Shape
Capsule/Oblong (hard gelatin capsule)
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novadoz Pharmaceuticals LLC
Manufacturer
MSN Laboratories Private Limited
National Drug Code (NDC)
72205-0118

Get help with Imprint Code FAQs.

Related images for "8 MS"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.